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ABSTRACT 
Nerve growth factor (NGF) binds to the NGF receptor, TrkA, at the tips of nerve cell axons, 
sending a signal that prevents programmed cell death and causes survival, growth, and 
differentiation of the nerve cell. Both NGF and TrkA have been demonstrated to be 
retrogradely transported from axon tips to nerve cell bodies, however the mechanism of this 
transport, and its function, is strongly debated. Using a recently developed cell fractionation 
protocol in conjunction with in vitro reactions using an ATP regenerating system, our lab has 
isolated small vesicles containing NGF bound to activated TrkA. These vesicles may provide 
a vehicle for retrograde transport of the NGF signal and initiation of signal transduction in the 
cell body. 
ERK.I is a serine/threonine kinase that is activated by NGF-activated TrkA. Prolonged ERKI 
activity is characteristic of cells stimulated by NGF. The purpose of the experiments in this 
thesis was to characterise the intracellular distribution and activity of ERKI before and after 
NGF stimulation, in rat pheochromocytoma (PCI2) cells, which are a good model for nerve 
cells. We have found that ERK.I activity is redistributed between cell compartments after 
NGF stimulation of PCI2 cells. ERKI activity increased in sedimentable fractions that 
emerged from mechanically permeabilised cells after NGF treatment and in vitro reactions 
with ATP. Importantly, the results from glycerol velocity gradient experiments showed that 
ERKl was not associated with membranes. Instead ERKl was found in a rapidly 
sedimenting particle whose sedimentation was not affected by detergent solubilisation. These 
results suggest that ERK.I is recruited into a protein complex, after activation, which may be 
an important step in signal transduction. Formation of this complex is likely to be 
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